849 related articles for article (PubMed ID: 27538949)
1. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
2. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
3. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
[TBL] [Abstract][Full Text] [Related]
4. Intranasal drug delivery to the central nervous system: present status and future outlook.
Tayebati SK; Nwankwo IE; Amenta F
Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
[TBL] [Abstract][Full Text] [Related]
5. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
7. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
8. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
Banks WA
Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
[TBL] [Abstract][Full Text] [Related]
9. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
10. Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain.
Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
CNS Neurol Disord Drug Targets; 2016; 15(9):1079-1091. PubMed ID: 27633786
[TBL] [Abstract][Full Text] [Related]
11. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
12. Targeting specific cells in the brain with nanomedicines for CNS therapies.
Zhang F; Lin YA; Kannan S; Kannan RM
J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of biologics to the central nervous system.
Lochhead JJ; Thorne RG
Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnologies: a strategy to overcome blood-brain barrier.
De Rosa G; Salzano G; Caraglia M; Abbruzzese A
Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Gao H; Pang Z; Jiang X
Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
[TBL] [Abstract][Full Text] [Related]
16. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
[TBL] [Abstract][Full Text] [Related]
17. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors.
Sharma HS; Sharma A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(2):184-203. PubMed ID: 22162425
[TBL] [Abstract][Full Text] [Related]
18. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
19. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
[TBL] [Abstract][Full Text] [Related]
20. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.
Govender T; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Modi G; Naidoo D; Pillay V
Pharm Dev Technol; 2017 Jun; 22(4):476-486. PubMed ID: 27268737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
